(Q37662238)
Statements
Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy (English)
Susan L Slager
Carrie A Thompson
Thomas E Witzig
Thierry Jo Molina
Cristine Allmer
Ivana N Micallef
Emmanuelle Nicolas-Virelizier
Richard Delarue
Hervé Ghesquières
Jean-Philippe Jais
Frédéric Peyrade
William R Macon
Nicolas Ketterer
Paul J Kurtin
Thomas M Habermann